Details of the Drug Combination

General Information of Drug Combination (ID: DCNMK6Y)

Drug Combination Name
Uridine triacetate Fludeoxyglucose F 18
Indication
Disease Entry Status REF
Brain Imaging Phase 4 [1]
Component Drugs Uridine triacetate   DM1WYDU Fludeoxyglucose F 18   DMAIL4L
Small molecular drug Small molecular drug
2D MOL 2D MOL
3D MOL 3D MOL

References

1 ClinicalTrials.gov (NCT04417998) Improving PET Image Quality and Quantification by Using Motion Correction, Parametric Imaging and MAP Reconstruction
2 ClinicalTrials.gov (NCT02110147) Open-Label Study of Uridine Triacetate in Pediatric Patients With Hereditary Orotic Aciduria. U.S. National Institutes of Health.
3 Uridine triacetate FDA Label
4 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015